An, Ming-Wen <br/><br/>
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignment.  [electronic resource] 

 -  Contemporary clinical trials  Jul 2014 
 - 157-62 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1559-2030 
<br/><br/><label>Standard No.: </label>10.1016/j.cct.2014.04.007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biomarkers<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Celecoxib<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Pyrazoles--therapeutic use<br/>Random Allocation<br/>Research Design<br/>Sample Size<br/>Sulfonamides--therapeutic use